Maugendre D, Chaillous L, Rohmer V, Lecomte P, Marechaud R, Saï P, Marre M, Charbonnel B, Allannic H, Delamaire M
Clinique Médicale B-F-Hôpital Sud, Rennes, France.
Diabetes Metab. 1997 Sep;23(4):320-6.
The frequency of 37/40 kD antibodies and their association with other pancreatic humoral markers were studied in 109 recently diagnosed Type 1 diabetic patients and 116 subjects with islet-cell antibodies (ICA) at various risk for this disease (64 relatives of Type 1 diabetic patients, 23 schoolchildren with no family history of diabetes, and 29 patients with Graves' disease). At the time of diagnosis, 37/40 kD antibodies were detected in 45% of Type 1a and 77% of Type 1b diabetic patients (p = 0.03). Antibodies to glutamic acid decarboxylase (GAD) and/or 37/40 kD were present with the same frequency as ICA (86%). The frequency of 37/40 kD antibodies was not significantly different between the 3 groups at risk, in contrast with GAD antibodies which were found at a lower frequency in schoolchildren (p < 0.02). Frequencies of other pancreatic markers (ICA cross-reactive with mouse pancreas and insulin autoantibodies) and the combination of ICA with at least two other markers were significantly higher in relatives than in the other groups at risk (p < 0.02). Out of 116 ICA-positive non-diabetic subjects, 10 developed diabetes. All 10 displayed 37/40kD and/or GAD antibodies during the prediabetic phase. In 8 of these 10 patients, ICA was combined with at least two other markers, whereas this association was detected in only 17 of the remaining 106 subjects who did not progress to diabetes (p < 10(-4). Thus, 37/40 kD antibodies were found in about half of Type 1 diabetic patients, and with a higher-frequency in Type 1b than 1a. In ICA-positive non-diabetic subjects, our date confirm that a combination of multiple antibodies, including GAD antibodies and 37/40 kD antibodies, can enhance the predictive value for diabetes. Comparison of ICA-positive relatives of diabetic patients, schoolchildren and patients with Graves' disease revealed distinct frequencies and combinations of markers of diabetes. This might reflect different patterns of progression among these 3 groups.
在109例新诊断的1型糖尿病患者以及116例处于不同发病风险的胰岛细胞抗体(ICA)阳性受试者(64例1型糖尿病患者的亲属、23例无糖尿病家族史的学童以及29例格雷夫斯病患者)中,研究了37/40 kD抗体的频率及其与其他胰腺体液标志物的关联。在诊断时,1a型糖尿病患者中有45%检测到37/40 kD抗体,1b型糖尿病患者中有77%检测到该抗体(p = 0.03)。谷氨酸脱羧酶(GAD)抗体和/或37/40 kD抗体的出现频率与ICA相同(86%)。有发病风险的3组人群中,37/40 kD抗体的频率无显著差异,而GAD抗体在学童中的发现频率较低(p < 0.02)。其他胰腺标志物(与小鼠胰腺交叉反应的ICA和胰岛素自身抗体)的频率以及ICA与至少两种其他标志物的组合在亲属中的频率显著高于其他有发病风险的组(p < 0.02)。在116例ICA阳性的非糖尿病受试者中,有10例发展为糖尿病。所有10例在糖尿病前期均表现出37/40 kD和/或GAD抗体。在这10例患者中的8例中,ICA与至少两种其他标志物组合,而在其余未发展为糖尿病的106例受试者中,仅17例检测到这种关联(p < 10⁻⁴)。因此,约一半的1型糖尿病患者中发现有37/40 kD抗体,且1b型中的频率高于1a型。在ICA阳性的非糖尿病受试者中,我们的数据证实包括GAD抗体和37/40 kD抗体在内的多种抗体组合可提高糖尿病的预测价值。对糖尿病患者的ICA阳性亲属、学童和格雷夫斯病患者的比较揭示了糖尿病标志物的不同频率和组合。这可能反映了这3组人群中不同的疾病进展模式。